157 related articles for article (PubMed ID: 18411412)
1. A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models.
Rapp M; Maurizis JC; Papon J; Labarre P; Wu TD; Croisy A; Guerquin-Kern JL; Madelmont JC; Mounetou E
J Pharmacol Exp Ther; 2008 Jul; 326(1):171-7. PubMed ID: 18411412
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.
Cussac C; Rapp M; Mounetou E; Madelmont JC; Maurizis JC; Godeneche D; Dupuy JM; Sauzieres J; Baudry JP; Veyre A
J Pharmacol Exp Ther; 1994 Dec; 271(3):1353-8. PubMed ID: 7996446
[TBL] [Abstract][Full Text] [Related]
3. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
[TBL] [Abstract][Full Text] [Related]
4. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of O6-alkylguanine-DNA alkyltransferase inhibitor in nude mice bearing human melanoma.
Cussac C; Mounetou E; Rapp M; Madelmont JC; Maurizis JC; Labarre P; Chollet P; Chabard JL; Godeneche D; Baudry JP
Drug Metab Dispos; 1994; 22(4):637-42. PubMed ID: 7956741
[TBL] [Abstract][Full Text] [Related]
6. O6-3-[131I]iodobenzylguanine: improved synthesis and further evaluation of a potential agent for imaging of alkylguanine-DNA alkyltransferase.
Vaidyanathan G; Affleck DJ; Norman J; Welsh P; Liu W; Johnson SP; Friedman HS; Zalutsky MR
Bioconjug Chem; 2004; 15(2):402-8. PubMed ID: 15025538
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.
Mühlhausen U; Schirrmacher R; Piel M; Lecher B; Briegert M; Piee-Staffa A; Kaina B; Rösch F
J Med Chem; 2006 Jan; 49(1):263-72. PubMed ID: 16392811
[TBL] [Abstract][Full Text] [Related]
8. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
9. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
10. O6-3-[125I]iodobenzyl-2'-deoxyguanosine ([125I]IBdG): synthesis and evaluation of its usefulness as an agent for quantification of alkylguanine-DNA alkyltransferase (AGT).
Shankar S; Zalutsky MR; Vaidyanathan G
Bioorg Med Chem; 2005 Jun; 13(12):3889-98. PubMed ID: 15911305
[TBL] [Abstract][Full Text] [Related]
11. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.
Penketh PG; Shyam K; Baumann RP; Remack JS; Brent TP; Sartorelli AC
Cancer Chemother Pharmacol; 2004 Apr; 53(4):279-87. PubMed ID: 14704831
[TBL] [Abstract][Full Text] [Related]
12. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
[TBL] [Abstract][Full Text] [Related]
13. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
[TBL] [Abstract][Full Text] [Related]
14. DNA sequence context affects repair of the tobacco-specific adduct O(6)-[4-Oxo-4-(3-pyridyl)butyl]guanine by human O(6)-alkylguanine-DNA alkyltransferases.
Mijal RS; Kanugula S; Vu CC; Fang Q; Pegg AE; Peterson LA
Cancer Res; 2006 May; 66(9):4968-74. PubMed ID: 16651455
[TBL] [Abstract][Full Text] [Related]
15. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.
Baumann RP; Shyam K; Penketh PG; Remack JS; Brent TP; Sartorelli AC
Cancer Chemother Pharmacol; 2004 Apr; 53(4):288-95. PubMed ID: 14685775
[TBL] [Abstract][Full Text] [Related]
16. Effect of alterations of key active site residues in O6-alkylguanine-DNA Alkyltransferase on its ability to modulate the genotoxicity of 1,2-dibromoethane.
Liu L; Watanabe K; Fang Q; Williams KM; Guengerich FP; Pegg AE
Chem Res Toxicol; 2007 Jan; 20(1):155-63. PubMed ID: 17226938
[TBL] [Abstract][Full Text] [Related]
17. Engineering substrate specificity of O6-alkylguanine-DNA alkyltransferase for specific protein labeling in living cells.
Juillerat A; Heinis C; Sielaff I; Barnikow J; Jaccard H; Kunz B; Terskikh A; Johnsson K
Chembiochem; 2005 Jul; 6(7):1263-9. PubMed ID: 15934048
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity evaluation of a novel combi-nitrosourea prodrug: Designed to release a DNA cross-linking agent and an inhibitor of O(6)-alkylguanine-DNA alkyltransferase.
Sun G; Zhang N; Zhao L; Fan T; Zhang S; Zhong R
Bioorg Med Chem; 2016 May; 24(9):2097-107. PubMed ID: 27041398
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of alkylguanine-DNA alkyltransferase: further evaluation of radioiodinated derivatives of O6-benzylguanine.
Shankar S; Zalutsky MR; Friedman H; Vaidyanathan G
Nucl Med Biol; 2006 Apr; 33(3):399-407. PubMed ID: 16631089
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of human O(6)-alkylguanine-DNA alkyltransferase by modified oligodeoxyribonucleotides containing O(6)-benzylguanine.
Pegg AE; Goodtzova K; Loktionova NA; Kanugula S; Pauly GT; Moschel RC
J Pharmacol Exp Ther; 2001 Mar; 296(3):958-65. PubMed ID: 11181929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]